Member Info for Newuncle

I have others shares in small plcs who have reported full year audited numbers for 2022 on time and without any issues. And we know there are major financial issues with DVRG using MSYS to bankroll itself through 2022 and now being on the hook for £1.4M...I mean £1.4M that almost the entire MCAP of MSYS now (£1.75M)......and all we get is yes we will publish in mid May and then oh actually by end of June...absolute joke management in the business, if there is actually any managing being done that is. No business news since last September and then all this BS over 2022 numbers.

Well not much one can say now. Will MSYS even survive this storm?

Sorry Jan 2022

From Jan 2021 and then he left.....

Glenn Tracey, CEO of Microsaic, commented: "If 2021 was about turnaround and transition, then 2022 is about significant business inflection. We have worked tirelessly in 2021, putting in place the necessary building blocks in and around our technology, extending our business model to cover workflows, software and services. "The COVID-19 era has demonstrated the resilience of humans and ingenuity of our scientists, and Microsaic's ability to respond quickly with solutions to real-world problems. Real-time detection is a central facet of advancing this human endeavour. Microsaic solutions are exceptionally well placed with their capability to operate in real-time and, increasingly, informed by prior data analysis. "I am absolutely delighted about how Microsaic has emerged from the COVID-19 era, stronger than how we entered it. I am very optimistic about the future prospects for the business."

I wonder what else GB can screw up here? There hasn't been a single piece of good business news since Sept 2022 here, Surely it's not asking too much for the company to tell us that it is actually doing stuff and not just visiting exhibitions and conferences....they have spent some £30MILLION on tech etc and what do we actually have to show for it as investors in MSYS plc?

Date Source Headline

15th May 2023 7:15 am RNS Audit update

18th Apr 2023 7:59 am RNS DeepVerge plc debtor

13th Mar 2023 10:10 am RNS Holding(s) in Company

28th Dec 2022 9:25 am RNS Holding(s) in Company

24th Nov 2022 2:05 pm RNS Second Price Monitoring Extn

24th Nov 2022 2:00 pm RNS Price Monitoring Extension

30th Sep 2022 7:00 am RNS Half-year Report

From advfn today, first positive post on that site for years....

sultan_md_uk15 May '23 - 11:40 - 1101 of 1101

Firstly, the claim that "the product just isn't strong enough" is not supported by the fact that Microsaic Systems has successfully sold its instruments to several clients, including multinational corporations like Pfizer and AstraZeneca, as well as government institutions like the UK's National Health Service (NHS).

Furthermore, the ongoing partnership with Avacta Group, a UK-based biotech company, shows that there is a potential for the technology to be used in high-throughput drug discovery, which can lead to substantial growth opportunities. It is also worth noting that the contract with Avacta is ongoing, which indicates that the partnership has been successful so far.

In terms of revenue, although Microsaic Systems reported a revenue of £0.4 million in 2021, it is important to consider the fact that the company has only recently started commercializing its products. Additionally, partnerships with major players in the industry can lead to significant revenue growth in the future.

Regarding the claim that the company should delist and become a small service company, it is worth noting that the company has been actively expanding its product portfolio. For example, in 2021, Microsaic Systems announced the launch of its second product line, the 4500 MiD, which is a more advanced version of its previous product. This indicates that the company is still investing in product development and is not solely focused on becoming a service company.

In terms of the claim that Microsaic's technology is not game-changing, it is important to note that the company's instruments offer advantages such as portability and speed, which are not found in traditional LC/MS systems. These advantages make the technology appealing to a variety of clients, particularly those in the pharmaceutical and biotech industries.

Overall, while there are challenges facing Microsaic Systems, such as competition from established players in the industry, there is evidence to suggest that the company has the potential for growth and success in the future. .................................................................................... Also just collected facts: DeepVerge plc: Microsaic has a collaboration agreement with DeepVerge, a company specializing in AI-powered microbial detection and diagnostics. Under the agreement, Microsaic's mass spectrometry technology is integrated with DeepVerge's AI platform to develop a solution for rapid detection and identification of microbial contamination. The collaboration was announced in 2020 and continues as of 2021.

Unimicro Technologies Inc.: In 2018, Microsaic signed an agreement with Unimicro Technologies Inc., a Chinese distributor of scientific equipment. Under the agreement, Unimicro became Microsaic's exclusive distributor for the MiD product line

Bought some this AM fwiw, more a punt than an investment though at this time, hopefully that will change. One positive is that MSYS did previously say most of the details on repayment of £1.4m DVRG debt have been agreed and another 6 weeks might even bring some real business news, still a mystery as to what the Chinese were doing at MSYS HQ earlier this year and would like to think something might yet show from that? And we have the Kingsfisher partnership too...about time that started provided something.

Usual kicking from Tom Winnifrith this morning

From that last RNS, usual business description: £30m invested in the tech......

About Microsaic Systems

Microsaic floated on AIM in 2011 to develop and commercialise micro-engineering chip-based mass spectrometry equipment. Having invested c. GBP30m over 20 years of development, Microsaic has a robust and innovative patent portfolio in cutting-edge technology designed and developed for "Industry 4.0" application. Microsaic serves markets in Human Health, Environmental Health and Diversified Industries. Microsaic's system solutions enable analytical detection and characterisation at the point-of-need, whether within a conventional laboratory setting, or within a bioprocessing facility for continuous MS detection data at multiple steps in the process workflow.

Microsaic's products and systems are commercially available through global markets via a network of regional and local partners, targeting its core laboratory, manufacturing and point of need applications

Back to all time low now with MCAP at just £1.9m and owed £1.4m by DVRG, something is just not right here and the company is either massively undervalued or.........

How can anyone take what this company says seriously ????

Microsaic expects to release its audited financial results for the year ended 31 December 2022 (the "FY22 Results") during the first half of May 2023. The phasing and quantities of receipts from DeepVerge in relation to this historic commercial debt will be subject to further discussion with the Company's auditors, and appropriate disclosures will be included within the FY22 Results.

Absolute joke of an update

0...33p the bid....kin ells bells

SP is not rising and yes they were sells, not buys

And another 6m dumped...fox sake

just when we were gaining some traction again some to55er of seller pops up with 5m dump...****

LTB,

I think it's simpler than that, DVRG mcap collapsed to just £4m, there 2023 revenues are likely to be in the high teens £m despite their precarious cash position and debt with MSYS people have been pushing DVRG very hard on Twitter as very undervalued on mcap v revenues for 2023. No seems to give a to55 about msys

Problem with that is that DVRG will be able to dictate terms of repayment values and timing, especially with Nigel as their CEO, there must be some serious conflicts of interest from that alone.

DeepVerge confirms that amounts are currently owed by DeepVerge group companies to Microsaic totalling approximately GBP1.4 million.

DeepVerge also confirms that a settlement plan ("Settlement Plan") has been proposed to Microsaic, the terms of which are substantially agreed, and that it has made an initial payment in line with that plan. In addition, DeepVerge confirms that Microsaic has continued to supply services to DeepVerge during 2023, and all amounts arising during the current financial year continue to be paid under normal 30 day terms, in line with commercial agreements between the two parties.

DeepVerge shares a common director, Nigel Burton, with Microsaic, and finalisation of the Settlement Plan will fall to be treated as a related party transaction

People piling into DVRG this week and again today, no one sniffing around MSYS though...guess DVRG have the advantage of no Gerry Brandon management team baggage now but MSYS still stuck with him. Seriously annoying now that GB effectively used MSYS to bankroll DVRG £1.4m debt in 2022.

23m dumped.....at 0.35 dt